港股異動丨贛鋒鋰業(1772.HK)逆勢漲逾4% 大行紛紛唱好
格隆匯6月2日丨贛鋒鋰業(1772.HK)逆勢漲逾4%,報119.2港元,暫錄得連續第三週上漲,最新總市值1656億港元。大摩今日發研報指,預期贛鋒鋰業的股價在未來60日有70%至80%機會將上升,指出在中國及全球新能源汽車強勁需求下,短期鋰價及公司盈利將有上升空間。大摩指,贛鋒鋰業擁有更先進技術,原材料自給自足水平亦較同行高,基於2022年預測市盈率44倍,給予目標價143港元,預期2021至2025年盈利複合增長率可達40%,評級“增持”。大和研報則稱,2021-2023年氫氧化鋰價格前景看漲,贛鋒鋰業有望受惠。大華繼顯預計鋰輝石精礦的供應緊缺將在2021年持續,贛鋒鋰業應能從中受惠。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.